Trial Profile
Drug Use-Results Survey of Gonalef (Subcutaneous injection 75/150, Subcutaneous injection pen 300/450/900) for Ovulation Induction in Patients with Anovulation or Oligo-Ovulation Accompanying Hypothalamic-Pituitary Dysfunction or Polycystic Ovary Syndrome Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Adverse reactions
- Sponsors Merck Serono
- 17 Aug 2018 New trial record